Neuroscience
Bipolar Disorder
100%
Antidepressant
88%
Dementia Praecox
85%
Major Depressive Disorder
72%
Depression
58%
Meta-Analysis
48%
Anti-Inflammatory
38%
Statin
34%
Mental Disorder
34%
Somatics
33%
Leukocyte
31%
Selective Serotonin Reuptake Inhibitor
30%
Escitalopram
30%
Typical Antipsychotic
26%
Quetiapine
26%
Nortriptyline
25%
Antipsychotic
19%
Bipolar Depression
17%
Anti-Infective Agents
16%
C-Reactive Protein
16%
Psychopharmacological Treatment
16%
Psychosis
15%
Non-Steroidal Anti-Inflammatory Drug
13%
Anti-Inflammatory Agent
13%
Psychoactive Drug
11%
Mood Disorder
11%
Body Mass Index
10%
Adverse Effect
9%
Placebo
9%
Pediatric Trauma
8%
Obsessive-Compulsive Disorder
8%
Tic Disorder
8%
Automutilation
7%
Auditory Hallucination
7%
Treatment-Resistant Schizophrenia
7%
Mannan Binding Lectin
7%
Research Design
7%
Renin
7%
Eating Disorder
7%
Treatment of Depression
7%
Panic Disorder
7%
Central Nervous System
7%
Anticonvulsant
7%
Angiotensin
7%
Diabetes Mellitus
7%
Cognitive Disorders
7%
Urokinase Receptor
7%
Sertraline
7%
Antipsychotic
7%
Interleukin 6
6%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
81%
Antidepressant
73%
Bipolar Disorder
52%
Infection
48%
Typical Antipsychotic
35%
Antipsychotic
29%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
28%
Selective Serotonin Reuptake Inhibitor
27%
Cohort Study
26%
Schizophrenia Spectrum Disorder
25%
Anti-Inflammatory Drug
25%
Clinical Trial
21%
Placebo
19%
Major Depression
19%
Depression
18%
Comorbidity
17%
Inflammation
17%
Randomized Clinical Trial
16%
Antiinflammatory Agent
16%
Prevalence
16%
Polypharmacy
15%
Psychotropic Agent
14%
Statin (Protein)
13%
Non-Steroidal Anti-Inflammatory Drug
12%
Antiinfective Agent
12%
Antibiotics
11%
Adverse Event
11%
Antibiotic Agent
11%
Mood Disorder
10%
Tolerability
10%
Drug System
9%
Glucocorticoid
9%
Diabetes Mellitus
9%
Side Effect
9%
Microbiome
9%
Autism
8%
Physical Disease
8%
Bipolar Depression
8%
Psychosis
8%
Cross-Sectional Study
8%
Disease Severity
7%
Olanzapine
7%
Metabolic Disorder
7%
Otitis Media
7%
Semaglutide
7%
Clozapine
7%
C Reactive Protein
7%
Glucagon Like Peptide 1 Receptor Agonist
7%
Lithium Ion
7%
Anticonvulsive Agent
7%
Medicine and Dentistry
Antidepressant
32%
Infection
31%
Symptom
27%
Typical Antipsychotic
26%
Systematic Review
25%
Disease
24%
Major Depressive Episode
24%
Bipolar Disorder
24%
Mental Disorder
24%
Meta-Analysis
22%
Depression
20%
Cohort Analysis
18%
Somatics
16%
Schizophrenia Spectrum Disorder
15%
Escitalopram
15%
Randomized Clinical Trial
15%
Polypharmacy
15%
Hazard Ratio
13%
Drug Therapy
13%
Proportional Hazards Model
11%
Outpatient
11%
Nortriptyline
10%
Treatment Response
9%
Maturity Onset Diabetes of the Young
9%
Cerebrospinal Fluid
9%
Selective Serotonin Reuptake Inhibitor
8%
Quetiapine
8%
Cross Sectional Study
8%
Adverse Event
8%
Potentially Inappropriate Medication
8%
Rating Scale
8%
Diagnosis
7%
C Reactive Protein
7%
Clozapine
7%
Pediatrics
7%
Microbiome
7%
Physical Disease
7%
Water-Electrolyte Imbalance
7%
Auditory Hallucination
7%
Lithium Ion
7%
Mannan Binding Lectin
7%
Interleukin-6
7%
Semaglutide
7%
Streptococcus Infection
7%
Cardiometabolic Risk
7%
Olanzapine
7%
Placebo
7%
Umbrella Review
7%
Antibiotic Therapy
7%
Thyroid Function
7%